FLT1 and peripheral arterial disease: Likewise, by analyzing human PAD muscle biopsies, Ganta et al. reported that VEGF165b prevents the activation of VEGFR1-STAT3 signaling by inhibiting angiogenesis and perfusion recovery in PAD muscle [10].